India and Pfizer at impasse over vaccine indemnity demand -sources
Pfizer (PFE.N) and the Indian government are at loggerheads over a demand by the U.S. drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world’s biggest markets, two sources told Reuters. India has not given any manufacturer of a COVID-19 […]
